Glean's most recent priced round set a $7.2 billion post-money valuation in its $150 million Series F in mid-2025, led by Wellington Management. As of early October 2026, secondary market quotes have eased to approximately $6.9 billion, reflecting modest share-price softening despite continued ARR expansion toward $300 million. Enterprise AI demand, customer deployments across Fortune 500 firms, and platform enhancements in search and agents have sustained growth, yet the implied revenue multiple has compressed to roughly 24x amid broader private-market caution. With October 31 only weeks away and no disclosed new financing, regulatory milestone, or major commercial announcement on the immediate horizon, shifts in trader-implied odds will hinge primarily on any unexpected secondary prints or credible reports of an imminent round.